AssuredPartners Investment Advisors LLC Makes New Investment in Medical Properties Trust, Inc. (NYSE:MPW)

AssuredPartners Investment Advisors LLC purchased a new stake in Medical Properties Trust, Inc. (NYSE:MPW) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 182,824 shares of the real estate investment trust’s stock, valued at approximately $722,000.

Several other hedge funds have also recently modified their holdings of MPW. Truvestments Capital LLC bought a new stake in Medical Properties Trust during the third quarter valued at about $31,000. Allworth Financial LP lifted its stake in Medical Properties Trust by 230.4% during the 4th quarter. Allworth Financial LP now owns 6,082 shares of the real estate investment trust’s stock valued at $26,000 after acquiring an additional 4,241 shares during the period. Verus Capital Partners LLC purchased a new stake in Medical Properties Trust in the fourth quarter valued at $40,000. RS Crum Inc. purchased a new stake in shares of Medical Properties Trust in the fourth quarter worth about $40,000. Finally, RFG Advisory LLC purchased a new stake in Medical Properties Trust in the 4th quarter worth approximately $40,000. Hedge funds and other institutional investors own 71.79% of the company’s stock.

Wall Street Analysts Forecast Growth

MPW has been the topic of several recent analyst reports. Royal Bank of Canada lifted their target price on shares of Medical Properties Trust from $4.00 to $5.00 and gave the company a “sector perform” rating in a research report on Monday, March 10th. Mizuho decreased their target price on shares of Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Thursday, December 5th. Truist Financial lowered their price target on Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating for the company in a report on Thursday, December 19th. Wells Fargo & Company lifted their target price on shares of Medical Properties Trust from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Monday, March 10th. Finally, BNP Paribas raised Medical Properties Trust from a “neutral” rating to an “outperform” rating and lifted their target price for the company from $5.00 to $9.00 in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $5.64.

Medical Properties Trust Price Performance

Medical Properties Trust stock opened at $6.21 on Friday. The stock has a market cap of $3.73 billion, a P/E ratio of -1.47, a price-to-earnings-growth ratio of 1.01 and a beta of 1.32. The company has a fifty day simple moving average of $5.21 and a 200-day simple moving average of $4.83. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69. Medical Properties Trust, Inc. has a 12-month low of $3.51 and a 12-month high of $6.55.

Medical Properties Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 10th will be issued a $0.08 dividend. The ex-dividend date is Monday, March 10th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 5.16%. Medical Properties Trust’s payout ratio is currently -8.42%.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.